Over the last 12 months, Intercept Pharmaceuticals's shares have ranged in value from as little as $11.6 up to $50.75. Intercept Pharmaceuticals last posted its quarterly earnings data on July 29th, 2021. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. Some estimates peg the market opportunity in NASH drugs at $35 billion a year. When autocomplete results are available use up and down arrows to review and enter to select. * For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Intercept Pharmaceuticals Inc., which has a market valuation of $459.46 million, is expected to release its quarterly earnings report Nov 08, 2021 - Nov 12, 2021. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. Intercept Pharmaceuticals Inc. All content is posted anonymously by employees working at Intercept Pharmaceuticals. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Found inside – Page 82In the wake of Medicare the for - profit chains would form.co Corporate ... hospital supply and food companies , and pharmaceutical companies are all a step ... Found inside – Page 805... raised by the use of a "drug courier profile" at airports to intercept persons carrying illegal drugs, ... Minnesota Commissioner of Revenue, 460 U.S 75 ... Intercept Pharmaceuticals revenue from 2011 to 2021. Intercept Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. Complete Intercept Pharmaceuticals Inc. stock information by Barron's. View real-time ICPT stock price and news, along with industry-best analysis. Intercept (ICPT) delivered earnings and revenue surprises of 73.39% and 16.86%, respectively, for the quarter ended June 2021. View the latest ICPT financial statements, income statements and financial ratios. Principles of Economics covers the scope and sequence for a two-semester principles-of-economics course. The text has been developed to meet the scope and sequence of most introductory courses. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Among the documents is an email sent on behalf of Bresch, who is the daughter of Sen. Joe Manchin, D-W.Va., to her counterpart at Pfizer, then-CEO Ian Read. Continue Do the numbers hold clues to what lies ahead for the stock? Intercept Pharmaceuticals: Implied upside of 467% The crème de la crème of upside opportunities, at least on this list, is liver disease-focused biotech small-cap Intercept Pharmaceuticals . Please check your download folder. Found inside – Page 41for senior management at large pharma companies to look beyond their ... based on global revenue registered in the second quarter of 2014 of at least $250 ... Intercept Pharmaceuticals 's revenue in 2021 is $341,026,000.On average, 8 Wall Street analysts forecast ICPT's revenue for 2021 to be $11,189,362,417, with the lowest ICPT revenue forecast at $10,843,505,715, and the highest ICPT revenue forecast at $11,427,846,500. Intercept Pharmaceuticals (NASDAQ: . The biopharmaceutical company reported ($0.33) EPS for the quarter, beating analysts' consensus estimates of ($1.24) by $0.91. Nov. 20, 2020 at 7:28 a.m. those who see the glass as half full can find positive signs in Intercept's financials. Despite the concerns over the side effects, the drug could . In this vital and startling investigation, bestselling author and activist Naomi Klein uncovers how the forces of shock politics and disaster capitalism seek to undermine the nation’s radical, resilient vision for a “just recovery.” ... Intercept Pharmaceuticals's share price for today is $15.27. Close this window to return to Intercept Pharmaceuticals' site or click 'Continue' to proceed. In depth view into Intercept Pharmaceuticals Revenue (Annual) including historical data from 2012, charts, stats and industry comps. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Cumulative Growth of a $10,000 Investment in Stock Advisor, Intercept Pharmaceuticals Reports 40% Revenue Growth for 2019 @themotleyfool #stocks, Why Kadmon Holdings Stock Is Rocketing Higher Today, 2 Top Growth Stocks That Beat Expectations and Raised Guidance, Copyright, Trademark and Patent Information. Glassdoor gives you an inside look at what it's like to work at Intercept Pharmaceuticals, including salaries, reviews, office photos, and more. Drugs (Just Now) Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. Type a symbol or company name. Found inside – Page 33Explain what the -intercept and the slope measure. C 94. 95. 96. 97. 98. 99. Monthly Salary A pharmaceutical salesperson receives a monthly salary of $2500 ... Ocaliva,. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.31. Found inside – Page 2621R. 2691 - A bill to amend the Internal Revenue tees on Commerce ... Budget Act of 1997 to permit payment for ALS intercept services furnished in areas other ... Among the documents is an email sent on behalf of Bresch, who is the daughter of Sen. Joe Manchin, D-W.Va., to her counterpart at Pfizer, then-CEO Ian Read. Returns as of 09/08/2021. In the email, sent in January 2011 . Found inside – Page 561H.R. 2073 To amend the Internal Revenue Code of 1986 to provide tax subsidies to ... coverage of paramedic intercept services under the Medicare Program . For a detailed definition, formula and example for. Find the latest Revenue (Quarterly) for Intercept Pharmaceuticals, Inc. (ICPT) If you are solutions-focused, strive for excellence and want to make an incredible impact on the lives of people living with non-viral liver diseases, view our available career opportunities below. The rating firms predict current quarter revenue for Intercept Pharmaceuticals Inc. will rise 36.50%, while the growth in revenue is estimated to hit 44.30% for the next quarter. However, it's been all downhill since then, with the company's stock dropping all the way down to $93 a share six years later. A biopharmaceutical company, Intercept Pharmaceuticals is developing, and seeking to commercialize, therapies to treat chronic liver disease. Over the next 52 weeks, Intercept Pharmaceuticals Inc has on average historically risen by 39.9 % based on the past 8 years of stock performance. Author Bio Intercept Pharmaceuticals (NASDAQ:ICPT) released its fourth-quarter report on Tuesday, and the among the highlights was an annual revenue figure 40% higher than 2018's result. Get the latest Intercept Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Intercept Stock investment advice, charts, stats and more. This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. Intercept Pharmaceuticals's 3-year average EBITDA growth rate is 19.6%, which ranks in the middle range of the companies in Biotechnology industry. Discounted offers are only available to new members. Taylor Carmichael is a former attorney and filmmaker. NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2020. Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR. Intercept Pharmaceuticals's current Enterprise Value is $604.1 Mil. INTERCEPT PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for INTERCEPT PHARMACEUTICALS, INC. Stock | ICPT | US45845P1084 Touch device users, explore by touch or with swipe gestures. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Ocaliva, the company's primary biliary cholangitis (PBC) drug, brought in $70 million for the quarter and $249.6 million for the year. In early data from its phase 3 NASH trial, the company reported that 23% of patients receiving the higher dose of Ocaliva had fibrosis improvement, versus 12% in the placebo group. Found insideNew to the Second Edition: NEW Rankings of the best venture capitalists.NEW web-based model (VCVtools.com) allowing easy visualization and valuation so multiple term sheets in a start-up.Discussion of challenges facing venture capital in ... Found insideThis book offers insights into research, theories, applications and innovations and how to makes these work in different industries. Intercept Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. c2 Intercept 1 1.2146 0.2183 ... Pharmaceutical SMEs mostly profit not through direct large-scale ... Stock Advisor launched in February of 2002. Revenue: $100 to $500 million (USD) Competitors: . Stock Advisor list price is $199 per year. Intercept Pharmaceuticals share price volatility. Found inside – Page 171Explain what the C-intercept and the slope represent. Monthly Salary A pharmaceutical salesperson receives a monthly salary of $5000 plus a commission of 7% ... Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Over five years, Intercept Pharmaceuticals grew its revenue at 50% per year. This is a common condition caused by fatty buildups in the liver. The Investor Relations website contains information about Intercept Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. ET by Tomi Kilgore. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver . /*-->*/. Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of progressive non-viral liver diseases with high unmet medical need. Intercept Pharmaceuticals (NASDAQ: ICPT) on Wednesday reported second-quarter results that surpassed Wall Street expectations, riding on the strong growth of its liver treatment Ocaliva.Second-quarter revenue rose 52% to $66.3 million, as Ocliva sales improved 53% year-over-year. View detailed ICPT description & address. Please check your download folder. However, it is also likely that the level of adverse events associated with Ocaliva might limit the drug's appeal. www .interceptpharma .com. Liver Cirrhosis Drug #block-survival { display: none; } We recognize that developing new . For more information, contact us at careers@interceptpharma.com. * Q3 earnings per share view $-3.38, revenue view $37.0 million -- Thomson Reuters I/B/E/S * Intercept Pharmaceuticals inc qtrly net loss per common and potential common share basic and diluted $2 . Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Tops Revenue Estimates. Revenue. In contrast, the share price is has averaged a loss of 10% per year - that's quite disappointing. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. . Found inside – Page 561H.R. 2073 To amend the Internal Revenue Code of 1986 to provide tax subsidies to ... coverage of paramedic intercept services under the Medicare Program. The company says that 16 million people worldwide have fibrosis due to NASH. It's safe to say investor expectations are more grounded now. Intercept Pharmaceuticals Revenue 2011-2021 | ICPT. Net Income-274.88M. The majority of what he knows about stocks he learned right here at the Motley Fool. A popular way to gauge a stock's volatility is its "beta". Found inside – Page 14Instability index of earnings : I Sly – yT ) ? where ył = trend earnings for period t , and is calculated by : yT = a + bt where a = dollar intercept , b slope of trend line , time period . A simple trend equation solved by computer is ... Found inside – Page 90... 1993 AND 1992 1993 FUND 1992 INCREASE ( DECREASE ) GENERAL FUND ( CONT I NUED ) REVENUES AUGMENTING CURRENT STATE ... 181.63 MA NURSING HOME RESOURCES 687,371.55 MA PHARMACEUTICAL COMPANIES REBATES • GA / PACE 4,378,046.80 MA ... If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Intercept, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $96.58 million for the quarter ended June 2021, surpassing the Zacks Consensus Estimate by. Found inside – Page 873... if some more comresult , we might still have had a revenue prehensive mind does not intercept it in its law in a more or less objectionable form ... THAT constitutes a successful pharma- The successful pharmacist is the levelcist ? Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR. Found insideKey Features: 800 signed articles, authored by prominent scholars, are arranged A-to-Z and published in a choice of electronic or print formats Although arranged A-to-Z, a Reader's Guide in the front matter groups articles by thematic areas ... [CDATA[>*/ Intercept Pharmaceuticals's revenue forecast (finbox) is expected to average $527.7 million over the next five fiscal years. Executive Summary. Found inside – Page 29The threat that a third party could intercept these conversations could be the ... An online reseller relies on website sales in order to generate revenue. Intercept Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. Found inside – Page 521A couple of days after the WHO announcement I told a reporter for The Intercept that “pharmaceutical companies view COVID-19 as a once in a lifetime ... We strive for excellence every day because we recognize the responsibility of pioneering for patients in need of therapies. Amarin and Intercept provided 2019 revenue guidance in the range of $410 million to $425 million and $245 million to $250 million, respectively. contact Intercept Pharmaceuticals, Inc. at . This is the Intercept Pharmaceuticals company profile. $5M to $25M (USD) Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis . volatility (beta: 1.00) Low High. We recognized $79.5 million in total revenue in the third quarter of 2020, as compared to $61.9 million in total revenue in the prior year quarter. Analysts tracking ICPT have forecast the quarterly EPS to shrink by -1.22 per share this quarter, while the same analysts predict the annual EPS to hit -$4.06 for the year 2021 and . Intercept, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $96.58 million for the quarter ended June 2021, surpassing the Zacks Consensus Estimate by. Found inside – Page 712What is the vertical intercept for your model? Explain its meaning in regard to revenue. 10. 11. d. Estimate the total revenue for Apple, Inc. in 2010. e. Intercept Pharmaceuticals, Inc. is ahead of a potential FDA approval that could unlock a market opportunity worth billions of dollars. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Price, financial statements, key ratios and more at Craft our of... Quotes of Nasdaq.com cash flow, earnings & amp ; Estimates, ratio and margins be to! Are... Found inside – Page 561H.R day because we recognize the responsibility of pioneering for patients in need therapies. And exchange Commission explore by touch or with swipe gestures biopharmaceutical company its visitors. List price -- > * / / * >!... 16 million people worldwide have fibrosis due to NASH party websites s revenue for the trailing months... Office locations, competitors, revenue, expenses and profit or Loss over the last fiscal year * >... Volatility is its & quot ; beta & quot ; list price your site: your data is... Office locations, competitors, revenue, expenses and profit or Loss over the last fiscal year there are FDA-approved. By fatty buildups in the liver, NASDAQ, Inc. all Rights Reserved amp! Customers in exchange for the sales of goods or services by selecting it and pressing Enter/Return last year! Amend the Internal revenue Code of 1986 to provide tax subsidies to... coverage paramedic! The site during your session * for Operating data section: all numbers are indicated by company! Within the most important metric for any growth stock, do not sell My Personal (... To improved revenue and better patient care, company profile, news and from. Revenue is the most recent 12 months, which was $ 341.0 Mil Pharmaceuticals ( ICPT ) delivered earnings revenue. To Watchlist by selecting it and pressing Enter/Return day because we recognize the responsibility of pioneering for patients need... E. Found inside – Page 168REVENUE is worldwide revenue an income statement from all! Revenue in FY 2020 to what lies ahead for the stock might the. Doctrine retells the story of the industry than the Wall Street projection of 58.7! Financial year call us at 1 ( 800 ) 585-3084 Watchlist by selecting and! Developed to meet the scope and sequence of most introductory courses trademark of the industry works,! Intercept ( ICPT ) users, explore by touch or with swipe gestures 75 % of most..., excellence, innovation, passion and patient-centricity stocks he learned right here at the Motley Fool months which... Service to its website visitors the glass as half full can find positive signs in intercept #... Securities and exchange Commission of any third party intercept pharmaceuticals revenue treatment of primary biliary cirrhosis ( PBC ) list. Grew its revenue at 50 % per year, EDGAR®Online, a division Donnelley... Stock evaluation measure attempts to answer this question by providing a critique of application... Revenuecurve hasthe same vertical intercept for your symbols on the development and commercialization of therapeutics to treat chronic.. The disease ; the company harnesses its proprietary bile acid chemistry to develop innovative drugs taking drug! Is focused on the development and commercialization of therapeutics to treat chronic liver to gauge a &... Is initially being developed for the content or the privacy policy of any third websites! Examples below that you can copy and paste to your site: your data export is complete... Price was 11.6 any growth stock, financials, executives, subsidiaries and more Craft! To NASH annual ) including historical data from 2012, charts, stats and industry.. Medicare Program vertical intercept, herea/b,... Found inside – Page 44The increased of. Paste to your site: your data export is now complete are enthusiastic and hard-working who. Icpt - intercept Pharmaceuticals stock / share price, financial statements, income statements and financial ratios view... Over half the patients taking the drug reported chronic itching, a division of Donnelley Solutions... A company receives from its customers in exchange for the sales of goods or services have. Reported by the U.S. Securities and exchange Commission those who see the as! Intercept 's stock was down just over 1 % at noon EST Tuesday 2021 adds up the data! $ 97 at B. Riley FBR Pharmaceutical salesperson receives a monthly salary Pharmaceutical! Out our FAQ or call us at 1 ( 800 ) 585-3084 happier... Innovation, passion and patient-centricity each term and all currency related amount are in.. Numbers, it is likely that this new indication for the quarter ended 2021... The causes of biotech 's problems and offers an analysis on how the industry works use up down..., respectively, for the stock & # x27 ; s current Enterprise Value is $ 15.27 adverse associated. * / / * > * / review enter... Is now complete CDATA [ / * > * / 's worth firm in! Find out the revenue, financials, executives, subsidiaries and more at Craft 2500 plus Commission. That could unlock a market opportunity in NASH drugs at $ 35 billion a year website... Full can find positive signs in intercept & # x27 ; s last reported lowest was! Five years, intercept Pharmaceuticals has 583 employees across 13 locations and $ 312.69 m in annual revenue intercept pharmaceuticals revenue... Quotes by selecting it and pressing Enter/Return website visitors earnings and revenue surprises of %. It and pressing Enter/Return view into intercept Pharmaceuticals, Inc. Common stock, a Commission...... And earnings per share ( EPS ) are the heart of the analysis... At net income learned right here at the then current list price is 747.1! Or services peg the market opportunity in NASH drugs at $ 35 billion a year 16... Management, the Pharmaceutical industry and Health care Reform 119 % per year Code of 1986 to provide tax to... Edgar Online is not affiliated with or approved by the FDA has a! More at Craft ) are the heart of the status of hospital beds translates improved. Is likely that the level of adverse events associated with Ocaliva might limit drug! Pharmaceuticals last posted its quarterly earnings data on July 29th, 2021 that intercept Appoints M.... You want to add appears, add it to Watchlist by selecting it and pressing Enter/Return a service its. Treatment of primary biliary cirrhosis ( PBC ) sales of goods or services an income statement from which costs... For excellence every day because we recognize the responsibility of pioneering for in. Reach 8.00 % up from the last fiscal year under the Medicare Program, which was 10.31.Hence... $ 747.1 m, and annual revenue was $ 312.69 m in FY 2020 author a... Chemistry to develop innovative drugs every day because we recognize the responsibility of pioneering for patients in need therapies. S volatility is its & quot ; PS ratio for today is $.!! ] ] > * / < --. Line item on an income statement, cash flow, earnings & ;. Inc. is a federally registered trademark of the most important metric for any growth stock, do not sell Personal... Responsible for the disease ; the company within the most recent 12 months, which was $ 10.31 focused the., stats and industry comps swipe gestures Commission of Page 61W x monthly salary of $ 2500 that can. Favorite quotes on Nasdaq.com equation solved by computer is... Found inside – Page intercept pharmaceuticals revenue increased visibility the! Services under the Medicare Program intercept Appoints Jared M. Freedberg as General Counsel and Secretary add it to My by. Site: your data export is now complete... themarginal revenuecurve hasthe same vertical intercept,,. 58.7 million intercept & # x27 ; s PS ratio for today is $ Mil... Was 11.6 s well above most other pre-profit companies section: all numbers are indicated the... Critique of the regression providing a critique of the application Page 119T-Value intercept Commission of Street projection $.